J. Christopher Naftzger Nabriva Therapeutics PLC (NBRV) insider trading activity

J. Christopher Naftzger is General Counsel and Corp Sec of Nabriva Therapeutics plc. Currently has a direct ownership of 7,000 shares of NBRV, which is worth approximately $2,800. The most recent transaction as insider was on Dec 27, 2021, when has been sold 7,000 shares (Ordinary Shares) at a price of $0.59 per share, resulting in proceeds of $4,130. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7K

0% 3M change

0% 12M change

Total Value Held $2,800

J. Christopher Naftzger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 27 2021	BUY Open market or private purchase	$4,130 $0.59 p/Share	7,000 Added 50.0%	7,000 Ordinary Shares

Also insider at

ABUS

Arbutus Biopharma Corp Healthcare

General Counsel and CCO

JCN